Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

USA - NASDAQ:RAY - VGG7385S1011 - Common Stock

2.625 USD
-0.5 (-16.08%)
Last: 11/7/2025, 8:11:26 PM
2.62 USD
0 (-0.19%)
After Hours: 11/7/2025, 8:11:26 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RAY. RAY was compared to 23 industry peers in the Distributors industry. RAY gets an excellent profitability rating and is at the same time showing great financial health properties. RAY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
In the past year RAY had a positive cash flow from operations.
Each year in the past 5 years RAY has been profitable.
RAY had a positive operating cash flow in each of the past 5 years.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

With an excellent Return On Assets value of 13.62%, RAY belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
RAY has a Return On Equity of 16.79%. This is in the better half of the industry: RAY outperforms 78.26% of its industry peers.
The Return On Invested Capital of RAY (11.76%) is better than 78.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RAY is significantly above the industry average of 14.79%.
The last Return On Invested Capital (11.76%) for RAY is well below the 3 year average (21.00%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROIC 11.76%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

RAY has a Profit Margin of 10.59%. This is amongst the best in the industry. RAY outperforms 95.65% of its industry peers.
In the last couple of years the Profit Margin of RAY has declined.
RAY has a Operating Margin of 9.48%. This is amongst the best in the industry. RAY outperforms 82.61% of its industry peers.
RAY's Operating Margin has declined in the last couple of years.
RAY has a Gross Margin of 22.10%. This is comparable to the rest of the industry: RAY outperforms 56.52% of its industry peers.
RAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RAY is creating value.
RAY has more shares outstanding than it did 1 year ago.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

RAY has an Altman-Z score of 5.46. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RAY (5.46) is better than 65.22% of its industry peers.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.46
ROIC/WACC1.17
WACC10.09%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

RAY has a Current Ratio of 5.29. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
RAY's Current ratio of 5.29 is amongst the best of the industry. RAY outperforms 91.30% of its industry peers.
RAY has a Quick Ratio of 5.19. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
RAY has a Quick ratio of 5.19. This is amongst the best in the industry. RAY outperforms 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.19
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for RAY have decreased strongly by -25.16% in the last year.
Measured over the past years, RAY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.14% on average per year.
The Revenue has grown by 22.00% in the past year. This is a very strong growth!
The Revenue has been growing by 20.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.25, which means the current valuation is very expensive for RAY.
Based on the Price/Earnings ratio, RAY is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
RAY's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.83.
Industry RankSector Rank
PE 26.25
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RAY indicates a somewhat cheap valuation: RAY is cheaper than 69.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 143.05
EV/EBITDA -1.61
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield N/A

RAYTECH HOLDING LTD

NASDAQ:RAY (11/7/2025, 8:11:26 PM)

After market: 2.62 0 (-0.19%)

2.625

-0.5 (-16.08%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.95%
Inst Owner ChangeN/A
Ins Owners19.79%
Ins Owner ChangeN/A
Market Cap114.45M
Revenue(TTM)121.99M
Net Income(TTM)12.92M
AnalystsN/A
Price TargetN/A
Short Float %0.91%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.25
Fwd PE N/A
P/S 7.29
P/FCF 143.05
P/OCF 143.05
P/B 11.56
P/tB 11.56
EV/EBITDA -1.61
EPS(TTM)0.1
EY3.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.7%
OCF(TTM)0.02
OCFY0.7%
SpS0.36
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.71
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROCE 15.03%
ROIC 11.76%
ROICexc N/A
ROICexgc N/A
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
FCFM 5.1%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 53.78%
Profit Quality 48.14%
Current Ratio 5.29
Quick Ratio 5.19
Altman-Z 5.46
F-Score4
WACC10.09%
ROIC/WACC1.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.86%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.5%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-60.5%
OCF growth 3Y-8.91%
OCF growth 5YN/A

RAYTECH HOLDING LTD / RAY FAQ

What is the fundamental rating for RAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to RAY.


What is the valuation status of RAYTECH HOLDING LTD (RAY) stock?

ChartMill assigns a valuation rating of 3 / 10 to RAYTECH HOLDING LTD (RAY). This can be considered as Overvalued.


Can you provide the profitability details for RAYTECH HOLDING LTD?

RAYTECH HOLDING LTD (RAY) has a profitability rating of 7 / 10.


How financially healthy is RAYTECH HOLDING LTD?

The financial health rating of RAYTECH HOLDING LTD (RAY) is 9 / 10.